FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns a prophylactic drug for vasculitis. Substance of the invention includes a preventive and/or therapeutic drug for vasculitis containing an antibody to an interleukine-6 (IL-6) receptor as an active ingredient and also method for vasculitis prevention and/or treatment.
EFFECT: development of the new drug expressing therapeutic effectiveness in vasculitis treatment.
39 cl, 4 ex, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AGENT IN SPINAL MARROW INJURY CONTAINING INTERLEUKINE-6 ANTAGONIST | 2004 |
|
RU2358761C2 |
| METHOD OF TREATING INTERLEUKIN-6-DEPENDENT DISEASES | 2004 |
|
RU2509574C2 |
| THERAPEUTIC AGENT FOR DISEASES, RELATED TO CHILDREN'S CHRONIC ARTHRITIC DISEASES | 2002 |
|
RU2361613C2 |
| THERAPEUTIC AGENT FOR TREATING DISEASES RELATED TO JUVENILE CHRONIC ARTHRITIS | 2002 |
|
RU2541165C2 |
| THERAPEUTIC AGENT FOR MESOTHELIOMA | 2004 |
|
RU2392967C2 |
| CHRONIC REJECTION INHIBITOR | 2008 |
|
RU2450829C2 |
| PROPHYLACTIC OR THERAPEUTIC AGENT FOR TREATING INFLAMMATORY INTESTINAL DISEASES CONTAINING IL-6 ANTAGONIST AS AN ACTIVE INGREDIENT | 1999 |
|
RU2195960C2 |
| THERAPEUTIC AGENT FOR MESOTHELIOMA | 2004 |
|
RU2554942C2 |
| AGENT FOR CARDIOPATHY | 2006 |
|
RU2450830C2 |
| DRUGS AGAINST CHRONIC RHEUMATIC ARTHRITIS CONTAINING ANTAGONIST OF IL-6 AS EFFECTIVE COMPONENT | 1995 |
|
RU2147443C1 |
